UCB SA (UCB) - Total Liabilities

Latest as of June 2026: €8.98 Billion EUR ≈ $10.50 Billion USD

Based on the latest financial reports, UCB SA (UCB) has total liabilities worth €8.98 Billion EUR (≈ $10.50 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore UCB SA (UCB) long-term investment share to see how much of total assets are deployed in long-term investments.

UCB SA - Total Liabilities Trend (2000–2025)

This chart illustrates how UCB SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see UCB SA total assets.

UCB SA Competitors by Total Liabilities

The table below lists competitors of UCB SA ranked by their total liabilities.

Company Country Total Liabilities
Agilent Technologies Inc
NYSE:A
USA $5.99 Billion
ASM INTL N.V. NY/1 EO-04
F:AVSN
Germany €1.54 Billion
Adani Power Limited
NSE:ADANIPOWER
India Rs758.78 Billion
WEG S.A.
SA:WEGE3
Brazil R$24.29 Billion
Asia Vital Components Co Ltd
TW:3017
Taiwan NT$124.68 Billion
Haleon plc
NYSE:HLN
USA $16.04 Billion
China CSSC Holdings Ltd
SHG:600150
China CN¥262.39 Billion
Adani Ports and Special Economic Zone Limited
NSE:ADANIPORTS
India Rs863.33 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down UCB SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of UCB SA to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.77 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.44 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how UCB SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for UCB SA (2000–2025)

The table below shows the annual total liabilities of UCB SA from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 €7.29 Billion
≈ $8.52 Billion
-0.37%
2024-12-31 €7.32 Billion
≈ $8.56 Billion
+11.49%
2023-12-31 €6.56 Billion
≈ $7.67 Billion
-3.53%
2022-12-31 €6.80 Billion
≈ $7.95 Billion
+16.83%
2021-12-31 €5.82 Billion
≈ $6.81 Billion
-3.69%
2020-12-31 €6.05 Billion
≈ $7.07 Billion
+48.50%
2019-12-31 €4.07 Billion
≈ $4.76 Billion
-4.39%
2018-12-31 €4.26 Billion
≈ $4.98 Billion
+1.87%
2017-12-31 €4.18 Billion
≈ $4.89 Billion
-11.70%
2016-12-31 €4.74 Billion
≈ $5.54 Billion
-12.48%
2015-12-31 €5.41 Billion
≈ $6.32 Billion
+2.89%
2014-12-31 €5.26 Billion
≈ $6.15 Billion
-3.29%
2013-12-31 €5.44 Billion
≈ $6.36 Billion
+14.05%
2012-12-31 €4.77 Billion
≈ $5.57 Billion
+9.46%
2011-12-31 €4.36 Billion
≈ $5.09 Billion
-0.50%
2010-12-31 €4.38 Billion
≈ $5.12 Billion
-6.93%
2009-12-31 €4.70 Billion
≈ $5.50 Billion
-14.60%
2008-12-31 €5.51 Billion
≈ $6.44 Billion
+4.08%
2007-12-31 €5.29 Billion
≈ $6.19 Billion
-7.50%
2006-12-31 €5.72 Billion
≈ $6.69 Billion
+147.83%
2005-12-31 €2.31 Billion
≈ $2.70 Billion
-32.29%
2004-12-31 €3.41 Billion
≈ $3.98 Billion
+160.76%
2003-12-31 €1.31 Billion
≈ $1.53 Billion
+23.83%
2002-12-31 €1.06 Billion
≈ $1.23 Billion
-10.05%
2001-12-31 €1.17 Billion
≈ $1.37 Billion
+6.95%
2000-12-31 €1.10 Billion
≈ $1.28 Billion
--

About UCB SA

BR:UCB Belgium Biotechnology
Market Cap
$46.88 Billion
€40.10 Billion EUR
Market Cap Rank
#646 Global
#4 in Belgium
Share Price
€210.30
Change (1 day)
-0.14%
52-Week Range
€196.50 - €285.40
All Time High
€285.40
About

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, … Read more